Breakingviews - Philipsâ€™ cardiac deal carries heart-stopping price
LONDON (Reuters Breakingviews) - Koninklijke Philips Chief Executive Frans van Houten wants to get out of the hospital. A key plank of his growth strategy for the $50 billion Dutch medical-technology group is selling equipment that allows doctors to care for their patients remotely, a field known as telehealth, which got a bump during the Covid-19 pandemic. The $2.8 billion acquisition of heart-monitor specialist BioTelemetry serves that purpose - but comes at a heart-stopping price.
